Cite

HARVARD Citation

    Moore, K. (2018). Clarification—safety and efficacy of apixaban versus warfarin in patients with end‐stage renal disease: Meta‐analysis. Pacing and clinical electrophysiology. 41 (7), p. 877. [Online]. 
  
Back to record